2001
DOI: 10.1038/35071124
|View full text |Cite
|
Sign up to set email alerts
|

The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

Abstract: When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle. Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene. The Cdc25A phosphatase activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis, but becomes degraded in response to DNA damage or stalled… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

49
864
8
12

Year Published

2003
2003
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 959 publications
(933 citation statements)
references
References 30 publications
49
864
8
12
Order By: Relevance
“…Interestingly, we repeatedly observed that the rate of DNA synthesis increased slightly at low dose(s) of irradiation in p53À/À and ATMÀ/À MEFs. This slight increase was consistent with that reported in cells from A-T patients (Falck et al, 2001). The low-dose-specific RDS in p53À/À MEFs was not owing to abrogation of a p53/p21 regulated G1/S-phase checkpoint in the cells, as suppression of DNA synthesis in p21À/À MEFs exhibited the same low-dose-specific sharp decrease as in WT MEFs in addition to the high-dose range moderate decrease (Figure 1a).…”
Section: Resultssupporting
confidence: 90%
See 3 more Smart Citations
“…Interestingly, we repeatedly observed that the rate of DNA synthesis increased slightly at low dose(s) of irradiation in p53À/À and ATMÀ/À MEFs. This slight increase was consistent with that reported in cells from A-T patients (Falck et al, 2001). The low-dose-specific RDS in p53À/À MEFs was not owing to abrogation of a p53/p21 regulated G1/S-phase checkpoint in the cells, as suppression of DNA synthesis in p21À/À MEFs exhibited the same low-dose-specific sharp decrease as in WT MEFs in addition to the high-dose range moderate decrease (Figure 1a).…”
Section: Resultssupporting
confidence: 90%
“…The low-dose component operates at doses below 2.5 Gy and is dependent on the functional p53. p53 was reported not to be required in the S-phase DNA damage checkpoint (Xie et al, 1998;Falck et al, 2001;Merrick et al, 2004). However, these studies used gamma-ray doses higher than 5 Gy, which are supra-lethal to the cells.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Two of the variants, a missense variant 470T4C (I157T) in exon 3 and a frameshift mutation 1100delC in exon 10, were the same as previously reported in patients with Li -Fraumeni syndrome (Bell et al, 1999), breast (Allinen et al, 2001;Vahteristo et al, 2002), and prostate cancer (Dong et al, 2003). The frameshift 1100delC mutation has been proven to result in the loss of kinase activity (Wu et al, 2001), and I157T variant has been shown to be defective in its ability to bind and phosphorylate Cdc25A, one of its normal substrates (Falck et al, 2001). These variants were further studied in a set of 1137 samples.…”
Section: Resultssupporting
confidence: 62%